cardiotoxicity screening
AsedaSciences and Clyde Biosciences Announce Commercial Agreement to Integrate Human-Relevant Cardiotoxicity Screening
AsedaSciences; Clyde Biosciences; 3RnD platform; CellOPTIQ; cardiotoxicity screening; New Approach Methods; NAMs